KEY POINTS: LGALS3 was increased in the process of AKI. The inhibition of LGALS3 alleviated kidney injury in vivo and in vitro. LGALS3 contributed to kidney injury by binding to the 3â²untranslated region of Nr4a1 through AAUAAA, leading to the activation of ferroptosis. BACKGROUND: AKI is a syndrome characterized by a precipitous decline in kidney function, posing a significant threat to patient survival. The role of RNA-binding protein in AKI remains insufficiently understood, and we found an important RNA-binding protein, LGALS3, that may mediate the progress of AKI. METHODS: Lgals3(â/â) mice, Nr4a1(â/â) mice, and cross-linking immunoprecipitation and high-throughput sequencing were performed to examine the role of Lgals3 in AKI and the targeted binding proteins. RESULTS: Lgals3 expression was notably elevated in vivo and in vitro AKI models. The inhibition of Lgals3 mitigated kidney injury in both in vivo and in vitro AKI models. Conversely, kidney-specific overexpression of Lgals3 exacerbated kidney damage. Mechanistically, Lgals3 bound to the 3â²-untranslated region of Nr4a1 through AAUAAA, resulting in upregulation of Nr4a1 and subsequent enhancement of Bap1 transcription, facilitating ferroptosis in AKI. Moreover, knockout of Nr4a1 or inhibition of the region of AAUAAA by antisense oligonucleotide conferred protection against Lgals3-induced ferroptosis in AKI models. CONCLUSIONS: LGALS3 contributed to kidney injury by binding to the 3â²untranslated region of Nr4a1 through AAUAAA, leading to the activation of ferroptosis.
RNA-Binding Protein Lgals3 , Ferroptosis, and Acute Kidney Injury.
RNA结合蛋白Lgals3、铁死亡和急性肾损伤
阅读:22
作者:Chen Lijia, Ye Zehua, Yang Songyuan, Xie Jinna, Li Haoyong, Zhou Xiangjun, Cheng Fan
| 期刊: | Journal of the American Society of Nephrology | 影响因子: | 9.400 |
| 时间: | 2025 | 起止号: | 2025 Feb 10; 36(7):1249-1263 |
| doi: | 10.1681/ASN.0000000638 | 研究方向: | 免疫/内分泌 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
